A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients

@inproceedings{Qunibi2011ARC,
  title={A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients},
  author={Wajeh Y. Qunibi and Carlos Mart{\'i}nez and M. H. Smith and Joseph Benjamin and Antoinette Mangione and Simon D. Roger},
  booktitle={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
  year={2011}
}
BACKGROUND Iron deficiency is a common cause of anaemia and hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) in non-dialysis-dependent chronic kidney disease (ND-CKD) patients. Current intravenous iron agents cannot be administered in a single high dose because of adverse effects. Ferric carboxymaltose, a non-dextran parenteral iron preparation, can be rapidly administered in high doses. METHODS This open-label trial randomized 255 subjects with glomerular filtration rates ≤ 45… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 83 CITATIONS, ESTIMATED 32% COVERAGE

Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia

VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Ferric Carboxymaltose: A Review in Iron Deficiency

VIEW 7 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Ferric Carboxymaltose: A Review of Its Use in Iron Deficiency

VIEW 10 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Intravenous versus oral iron for treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease.

  • Anne Marie Liles
  • Medicine
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2012
VIEW 2 EXCERPTS
CITES METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2011
2019

CITATION STATISTICS

  • 8 Highly Influenced Citations

  • Averaged 10 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 37 REFERENCES

Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.

VIEW 1 EXCERPT

Ferumoxytol for treating iron deficiency anemia in CKD.

VIEW 2 EXCERPTS